Junfeng Liu

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial

Dongsheng Yue, Shidong Xu, Qun Wang et al. · The Lancet Respiratory Medicine · 2018 · 288 citations

Medicine, Pathology, Erlotinib Versus Vinorelbine +8

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Liqun Wu, Herui Yao, Hui Chen et al. · Nature Communications · 2022 · 123 citations · Full text

Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses

Mark A. Merlin, Matthew D. Saybolt, Raffi Kapitanyan et al. · The American Journal of Emergency Medicine · 2010 · 76 citations

Opioid Epidemic, Intranasal Naloxone Delivery, Health Sciences +11

MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2

Feng Gao, Hao Wu, Rui Wang et al. · Bioengineered · 2019 · 62 citations · Full text

Lung Inflammation, Pathology, Cancer Biology +16

MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer

Qiang Zhen, Junfeng Liu, Lina Gao et al. · Cytogenetic and Genome Research · 2015 · 60 citations